Skip to main content

Table 4 Anti-hyperlipidemic activity for EZ heads on Triton induced hyperlipidemic rat’s

From: Characterization and interactions between piperine and ezetimibe in their Anti-hyperlipidemic efficacy using Biopharmaceutics and Pharmacokinetics

Group

TG (mmol/L)

TC (mmol/L)

LDL (mmol/L)

HDL (mmol/L)

VLDL (mmol/L)

I

92.36 ± 1.95

165.94 ± 1.26

80.36 ± 2.34

68.53 ± 1.26

20.64 ± 0.24

II

223.47 ± 0.63

259.36 ± 1.34

201.26 ± 1.36

12.34 ± 0.35

52.31 ± 0.41

III

130.64 ± 0.85

195.84 ± 0.95

152.34 ± 2.59

39.64 ± 0.94

33.64 ± 0.31

IV

124.13 ± 1.04

185.74 ± 0.86

146.29 ± 3.12

46.24 ± 0.56

28.95 ± 0.26

V

115.64 ± 1.34

179.43 ± 0.36

124.75 ± 2.61

52.31 ± 0.67

26.49 ± 0.35

VI

106.95 ± 1.26

165.34 ± 0.62

109.46 ± 2.05

56.98 ± 0.83

20.64 ± 0.24

VII

101.42 ± 0.95

156.22 ± 0.52

98.54 ± 1.34

63.51 ± 0.46

19.35 ± 0.21